IDRI receives grant to develop TB vaccine
The vaccine, ID93/GLA-SE contains fusion protein of four antigens and a synthetic adjuvant formulation, which together enable T-cells to induce effective immunity and protect against TB ID93/GLA-SE will
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Alpha-2b incorporates the company’s Biphasix drug delivery technology and provides a better means of delivering interferon-alpha-2b therapeutically to human papillomavirus (HPV) infected tissues. FDA will take 30 days